- Potential benefitMay increase public awareness leading to earlier screening among high-risk individuals.
- Potential benefitCould spur targeted outreach and education for disproportionately affected communities.
- Potential benefitMay catalyze advocacy, fundraising, and private-sector research investment focused on TNBC.
Expressing support for the designation of March 3, 2025, as "National Triple-Negative Breast Cancer Day".
Referred to the House Committee on Oversight and Government Reform.
This resolution is a simple House resolution that expresses support for designating March 3, 2025, as National Triple-Negative Breast Cancer Day. It is a nonbinding statement by the House intended to raise awareness about triple-negative breast cancer and encourage action. It does not create law, allocate funds, or require the President or federal agencies to take any action.
This House resolution expresses support for designating March 3, 2025, as “National Triple-Negative Breast Cancer Day” to raise awareness about triple-negative breast cancer and the need for action to address it.
It notes clinical characteristics, disproportionate impacts on young, Black, Hispanic, and BRCA-positive people, and the disease's share of breast cancer deaths.
As a House simple resolution it is ceremonial and does not create law; adoption in the House is likely but it does not become statute.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution: it clearly states the rationale for designating March 3, 2025 as National Triple-Negative Breast Cancer Day and provides sufficient, proportionate textual structure for a symbolic expression of support.
Liberal emphasizes health equity and research funding follow-up
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenThe designation is symbolic and does not authorize funding, programs, or regulatory changes.
- Potential burdenLimited direct effect on research funding, treatment development, or patient outcomes without follow-up.
- Potential burdenAdds to proliferation of awareness days, potentially diluting public and media attention overall.
Why the argument around this bill splits.
Liberal emphasizes health equity and research funding follow-up
Likely to welcome the designation as a useful awareness tool highlighting health disparities and the need for targeted research and support.
Will view the resolution as a symbolic step that could help mobilize funding and policy attention for disadvantaged groups.
Generally favorable as a noncontroversial awareness resolution that recognizes a serious public-health issue.
Would look for modest, evidence-based next steps and clarity that designation is symbolic, not an unfunded mandate.
Likely supportive but less enthusiastic; views the resolution as a symbolic recognition of a medical concern.
May caution against conflating recognition with federal spending or regulatory obligations.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
As a House simple resolution it is ceremonial and does not create law; adoption in the House is likely but it does not become statute.
- Whether sponsors seek only House adoption or a companion Senate measure
- Committee action timing and floor scheduling
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberal emphasizes health equity and research funding follow-up
As a House simple resolution it is ceremonial and does not create law; adoption in the House is likely but it does not become statute.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution: it clearly states the rationale for designating March 3, 2025 as National Triple-Negative Breast Cancer Day and provide…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.